Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) — The “Cardiovascular Surgical Devices Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts” has been added to ResearchAndMarkets.com’s offering.
The cardiovascular surgical devices market is expected to rise from around US$2.18 billion in 2025 to approximately US$2.86 billion by 2033, seeing a CAGR of 3.45% in this nine-year period. Factors such as increasing cardiovascular disease incidents, great developments in surgical technologies, and more pronounced interest in minimally invasive procedures are the key major influences on the market. These trends are going to influence cardiac healthcare positively on a global scale.
Cardiovascular surgery encompasses a category of surgical operations that target various diseases and conditions of the heart and vascular system. This specialized field includes coronary artery bypass grafting (CABG), heart valve repair or replacement, and surgeries for congenital heart defects. Surgical intervention in cardiovascular surgery has played a paramount role in the management of such conditions as coronary artery disease, heart failure, and aneurysms, which have greatly improved patient outcomes and increased quality of life.
The global increase in the prevalence of heart-related ailments because of lifestyle choices, aging of the population, and enhanced sensitization about heart health greatly influences the popularity of cardiovascular surgery. Improved surgical techniques and technologies, such as minimally invasive procedures and robotic-assisted surgeries, have added to the popularity by offering patients quicker recoveries and shorter lengths of stay in hospitals.
Most health facilities are now focusing on cardiovascular health, which means that more resources are being put into the surgical facilities and training programs. As demands for effective cardiac care continue to rise, cardiovascular surgery is still one of the leading edges of medical advancement, with research still going on to improve techniques and outcomes for patients worldwide.
Top Cardiovascular Surgical Devices Manufacturers
Abbott Laboratories
Abbott Laboratories is one of the leading medical device and healthcare companies that discovers, develops, manufactures, and sells diversified products in the world market. The business portfolio of Abbott comprises gastroenterology and women’s health, cardiovascular and metabolic health, pain management, central nervous system disorders, and many more. It also covers respiratory drugs and vaccines, biosimilars, core laboratory systems, and transfusion medicine technologies along with point-of-care systems. Its portfolio also comprises rapid diagnostic lateral flow tests, informatics and automation solutions, nutritional products, and rhythm management, electrophysiology, and heart failure-related devices. Its product portfolio encompasses a wide range of vascular and structural heart needs as well as neuromodulation therapies. Abbott undertakes to market its products primarily through wholesalers, distributors, government agencies, healthcare facilities, pharmacies, and retail buyers, among independent retailers. The company markets its products in North America, Latin America, the Middle East, Europe, the Asia-Pacific, and Africa.
Boston Scientific Corporation
Boston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery. Boston Scientific supplies its products to hospitals, clinics, outpatient facilities, and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia, and Puerto Rico. It markets products directly and through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific, and the Americas.
Edwards Lifesciences
Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company. It develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The company’s products comprise surgical valve repair devices, surgical valve replacement, hemodynamic monitoring devices, transcatheter heart valves, pressure monitoring devices, and related instruments and accessories. Its products find application for various therapies such as transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through a direct sales force and a network of independent distributors in North America, Europe and Asia-Pacific.
Cardinal Health Inc.
Cardinal Health Inc (Cardinal Health) is a provider of integrated healthcare products and services. The company’s major activities include the distribution of pharmaceuticals, manufacturing and distribution of medical and laboratory products, and providing performance and data solutions for healthcare facilities. It distributes branded and generic drugs, specialty medicines, over-the-counter healthcare and consumer products, medical equipment, surgical devices and laboratory products. The company operates nuclear pharmacies and cyclotron facilities and produces its own line of private branded medical and surgical products. Its customers also include retail customers such as chain and independent drug stores and pharmacies in supermarkets and mass merchandisers, hospitals, ambulatory care centers, physician offices, clinical laboratories and alternative care providers including mail order customers. The company operates in the US, Canada, Australia, China and Japan.
Medtronic PLC
Medtronic plc (Medtronic) is a medical technology company that designs, develops, manufactures, and markets medical devices and solutions. The major activities of the company include research, design, manufacture, and sale of biomedical engineering products. It offers products used in the treatment of heart valve disorders, heart failure, coronary artery diseases, aortic, peripheral vascular, venous renal and neurological diseases, spine and musculoskeletal disorders, as well as diseases of the ear, nose, and throat. Medtronic also provides biologic solutions for the orthopedic and dental markets. The company provides its products to hospitals, third-party healthcare providers, clinics, institutions including governmental healthcare programs, distributors, and group purchasing organizations in Asia Pacific, Europe, the Americas, the Middle East, and Africa.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2025 – 2033 |
| Estimated Market Value (USD) in 2025 | $2.18 Billion |
| Forecasted Market Value (USD) by 2033 | $2.86 Billion |
| Compound Annual Growth Rate | 3.4% |
| Regions Covered | Global |
Companies Featured
- Abbott Laboratories
- Boston Scientific Corporation
- Edwards Lifesciences
- Cardinal Health Inc.
- Medtronic PLC
- GE Healthcare
- LivaNova PLC
- Terumo Corporation
- Getinge AB
- MicroPort Scientific Corporation
- B. Braun Melsungen AG
- Zimmer Biomet Holdings, Inc.
- W. L. Gore & Associates, Inc.
- Jarvik Heart, Inc.
- Berlin Heart GmbH
For more information about this report visit https://www.researchandmarkets.com/r/fcm58j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Cardiovascular Surgical Devices Market
